Vita Life Sciences Limited (ASX:VLS)
2.270
-0.230 (-9.20%)
Jan 30, 2026, 3:41 PM AEST
Vita Life Sciences Revenue
Vita Life Sciences had revenue of 45.54M AUD in the half year ending June 30, 2025, with 32.24% growth. This brings the company's revenue in the last twelve months to 85.60M, up 9.13% year-over-year. In the year 2024, Vita Life Sciences had annual revenue of 79.51M with 8.28% growth.
Revenue (ttm)
85.60M
Revenue Growth
+9.13%
P/S Ratio
1.60
Revenue / Employee
244.57K
Employees
350
Market Cap
136.55M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 79.51M | 6.08M | 8.28% |
| Dec 31, 2023 | 73.43M | 6.54M | 9.78% |
| Dec 31, 2022 | 66.89M | 9.78M | 17.14% |
| Dec 31, 2021 | 57.10M | 10.62M | 22.85% |
| Dec 31, 2020 | 46.48M | 4.03M | 9.49% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Vitura Health | 124.04M |
| Medical Developments International | 39.06M |
| Little Green Pharma | 38.49M |
| Next Science | 33.66M |
| IDT Australia | 19.77M |
| ECS Botanics Holdings | 19.36M |
| Peak Processing | 15.49M |
| Cann Group | 13.25M |